Effects of Low-Intensity Endurance Training on Aerobic Fitness and Risk Factors of Cardiometabolic Health in Working-Age Adults: A Systematic Review and Meta-Analysis

低强度耐力训练对工作年龄成年人有氧适能和心血管代谢健康风险因素的影响:系统评价和荟萃分析

阅读:1

Abstract

There is a lack of meta-analyses focusing on low-intensity endurance training (LIT), including considerations of the lowest effective intensity across different outcomes. This systematic review and meta-analysis examined the effects of LIT on aerobic fitness and cardiometabolic health. Randomized controlled trials involving healthy adults aged 18-65 were included if the training intervention was ≥ 3 weeks, intensity was exclusively below the first lactate/ventilatory threshold (VT1), or ≤ 60% heart rate reserve, or maximum oxygen uptake (VO(2max)), or ≤ 75% maximum heart rate. Outcome variables were VO(2max), VT1, systolic and diastolic blood pressure, plasma/serum low-density, high-density, and total cholesterol, triglycerides, and glucose. Effect sizes (ES) were calculated according to Hedge's g. The subgroup analyses (Q-test) examined the effects of training and background characteristics on outcomes. A total of 50 studies with 824 participants in the intervention groups were included. LIT had a large effect on relative VO(2max) (ES = 0.94, p < 0.001, I(2) = 0.73) and a moderate effect (ES = 0.74, p = 0.003, I(2) = 0.57) on VT1 compared with the control group. Small but significant effects (|ES| = 0.29-0.44, p < 0.05, I(2) = 0.39-0.79) were observed for other variables, excluding glucose. According to the subgroup analysis, exercise intensity was associated with the adaptations only in VO(2max) (p = 0.02). LIT improved aerobic fitness and cardiometabolic health, but effects on fitness were more pronounced. Although higher exercise intensity was associated with greater adaptations in VO(2max), no minimum intensity for adaptations was detected for most outcomes. Notable heterogeneity in responses was observed, which likely reflects both methodological differences (e.g., intensity prescription) between studies and uncertainty regarding the response magnitude. Trial Registration: The review protocol was registered at PROSPERO (CRD42023469528).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。